Skip to main content

Advertisement

Table 1 Descriptive statistics of 41 patients treated with CLZ

From: Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia

Parameters N Mean ± SE Median (range)
Age (years)
 Male 22 (53.7%) 34.68 ± 1.58 36 (23–50)
 Female 19 (46.3%) 31.58 ± 1.29 35 (26–43)
CLZ time (months)
 Male   10.05 ± 1.74 10 (1–32)
 Female   6.63 ± 1.15 6 (1–24)
CLZ dose (mg/day)
 Male   222.73 ± 42.95 150 (100–900)
 Female   105.26 ± 8.46 100 (50–200)
CLZ levels (ng/mL)
 Male   290.11 ± 51.56 203.25 (44–846)
 Female   336.36 ± 29.16 321.77 (91–572)
DMC levels (ng/mL)
 Male   134.98 ± 12.78 108.93 (28–308)
 Female   127.17 ± 16.91 133.78 (47–245)
   Number of subjects (percentage)  
Tobacco smokers   12.2% (n = 5)  
Marijuana smokers   4.9% (n = 2)
Drink alcohol (alcoholism)   7.3% (n = 3)
Drink coffee   14.6% (n = 6)